Poul Sorensen
Technik-/Wissenschafts-/F&E-Leiter bei Novelix Pharmaceuticals, Inc.
Profil
Poul Sorensen is Chief Science Consultant of Novelix Pharmaceuticals, Inc. He is Director of the Tumor Genetics Laboratory and a Professor of Pathology at the University of British Columbia, and a Senior Scientist at the British Columbia Cancer Research Centre in Vancouver, Canada.
Dr. Sorensen has over 15 years experience in tumor biology and cancer drug target identification.
Aktive Positionen von Poul Sorensen
| Unternehmen | Position | Beginn |
|---|---|---|
Novelix Pharmaceuticals, Inc.
 Novelix Pharmaceuticals, Inc. Medical/Nursing ServicesHealth Services Novelix Pharmaceuticals, Inc. is a biotechnology company. The firm manufactures pharmaceutical products. It focuses on lung, colon and dermato-oncology indications. The company was founded by Jeremy Teraoka and Burkhard Jansen in 2005 and is headquartered in Encinitas, CA. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.1995 |
| University of British Columbia | Corporate Officer/Principal | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
Novelix Pharmaceuticals, Inc.
Novelix Pharmaceuticals, Inc. Medical/Nursing ServicesHealth Services Novelix Pharmaceuticals, Inc. is a biotechnology company. The firm manufactures pharmaceutical products. It focuses on lung, colon and dermato-oncology indications. The company was founded by Jeremy Teraoka and Burkhard Jansen in 2005 and is headquartered in Encinitas, CA. | Health Services |
